The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4
Open accessAbstract
Cancer incidence is rising and this global challenge is further exacerbated by tumour resistance to available medicines. A promising approach to meet the need for improved cancer treatment is drug repurposing. Here we highlight the potential for repurposing disulfiram (also known by the trade name Antabuse), an old alcohol-aversion drug that has been shown to be effective against diverse cancer types in preclinical studies. Our nationwide epidemiological study reveals that patients who continuously used disulfiram have a lower risk of death from cancer compared to those who stopped using the drug at their diagnosis. Moreover, we identify the ditiocarb-copper complex as the metabolite of disulfiram that is responsible for its anti-cancer effects, and provide methods to detect preferential accumulation of the complex in tumours and candidate biomarkers to analyse its effect on cells and tissues. Finally, our functional and biophysical analyses reveal the molecular target of disulfiram's tumour-suppressing effects as NPL4, an adaptor of p97 (also known as VCP) segregase, which is essential for the turnover of proteins involved in multiple regulatory and stress-response pathways in cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“DIS`s definitive antineoplastic mechanism of action, identified over the past decade, involves the molecular target NPL4, which is an adapter for the p97/VCP segregase and is essential for protein turnover, playing a role in several regulatory and stress-responsive cellular pathways.26”
From Off-label and repurposed use of disulfiram beyond alcohol dependence: A systematic review of clinical and preclinical evidence (2026) · cites this paper as [26]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“a nationwide epidemiological study revealed that patients who continuously used DIS have a lower risk of death from cancer compared to those who stopped using the drug at their diagnosis.26”
From Off-label and repurposed use of disulfiram beyond alcohol dependence: A systematic review of clinical and preclinical evidence (2026) · cites this paper as [26]
The cited source says what the claim attributes to it.
In the citing paper
“This triggers a multifaceted cellular stress response culminating in cell death,26”
From Off-label and repurposed use of disulfiram beyond alcohol dependence: A systematic review of clinical and preclinical evidence (2026) · cites this paper as [26]
The cited source says what the claim attributes to it.
In the citing paper
“Intracellular Cu(DDC)2 binds NPL4, inducing aggregation that disrupts the essential p97-NPL4-UFD1 segregase pathway.”
From Off-label and repurposed use of disulfiram beyond alcohol dependence: A systematic review of clinical and preclinical evidence (2026) · cites this paper as [26]
The cited source says what the claim attributes to it.
In the citing paper
“DIS’s cytotoxic activity stems from its rapid metabolism to Cu(DDC)2, which preferentially accumulates in tumors.”
From Off-label and repurposed use of disulfiram beyond alcohol dependence: A systematic review of clinical and preclinical evidence (2026) · cites this paper as [26]
The cited source says what the claim attributes to it.
In the citing paper
“This initial observation has since been substantiated through extensive research, including analyses of Danish demographic and health registries that observed lower mortality rates for colon, prostate, and breast cancers among ongoing DSF users compared to former users.111”
From Drug repurposing for cancer therapy (2024) · cites this paper as [111]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The central role of the propensity score in observational studies for causal effects
ROSENBAUM, P. R., & RUBIN, D. B. (1983) · Biometrika · doi:10.1093/biomet/70.1.41 · Cited by 31,241
Molecular Chaperone Functions in Protein Folding and Proteostasis
Kim, Y., Hipp, M. S., Bracher, A., Hayer-Hartl, M. K., & Hartl, F. U. (2013) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060208-092442 · Cited by 1,545
Target identification using drug affinity responsive target stability (DARTS)
Lomenick, B., Hao, R., Jonai, N., Chin, R., Aghajan, M., Warburton, S., Wang, J., Wu, R. P., Gómez, F., Loo, J. A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910040106 · Cited by 1,130
Thygesen, L. C., Daasnes, C., Thaulow, I., & Brønnum‐Hansen, H. (2011) · Scandinavian Journal of Public Health · doi:10.1177/1403494811399956 · Cited by 1,089
Role of Rpn11 Metalloprotease in Deubiquitination and Degradation by the 26 S Proteasome
Verma, R., Aravind, L., Oania, R. S., McDonald, W. H., Yates, J. R., Koonin, E. V., & Deshaies, R. J. (2002) · Science · doi:10.1126/science.1075898 · Cited by 994
Self-citationDoil, C., Mailand, N., Bekker‐Jensen, S., Ménard, P., Larsen, D. H., Pepperkok, R., Ellenberg, J., Panier, S., Durocher, D., Bártek, J., et al. (2009) · Cell · doi:10.1016/j.cell.2008.12.041 · Cited by 982
Emerging functions of the VCP/p97 AAA-ATPase in the ubiquitin system
Meyer, H. H., Bug, M., & Bremer, S. (2012) · Nature Cell Biology · doi:10.1038/ncb2407 · Cited by 832
Chen, D., Cui, Q. C., Yang, H., & Dou, Q. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2126 · Cited by 683
Self-citationCell death assays for drug discovery
Kepp, O., Galluzzi, L., Lipinski, M. M., Yuan, J., & Kroemer, G. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3373 · Cited by 587
Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice
Becker, L. A., Huang, B., Bieri, G., Ma, R., Knowles, D. A., Jafar-Nejad, P., Messing, J., Kim, H. J., Soriano, A., Auburger, G., et al. (2017) · Nature · doi:10.1038/nature22038 · Cited by 571
Cited by
Sorted by citations
Items 301–400 of 812
Overcoming Drug Resistance in Advanced Prostate Cancer by Drug Repurposing
Bahmad, H. F., Demus, T., Moubarak, M. M., Daher, D., Moreno, J. C. A., Polit, F., López, O., Merhe, A., Abou-Kheir, W. G., Nieder, A. M., et al. (2022) · Medical Sciences · doi:10.3390/medsci10010015 · Cited by 27
Identification of copper-related biomarkers and potential molecule mechanism in diabetic nephropathy
Ming, J., Sana, S. R. G. L., & Deng, X. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.978601 · Cited by 26
Zhu, Y., Wang, N., Ling, J., Yang, L., Omer, A. M., Yang, G., & Yang, G. (2024) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2024.01.121 · Cited by 26
Xu, X., Li, H., Tong, B., Zhang, W., Wang, X., Wang, Y., Tian, G., Xu, Z., & Zhang, G. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202400204 · Cited by 26
Yao, W., Xu, Q., Ochsenreither, S., Ferrone, S., DeLeo, A. B., Sudhoff, H. H., Oppel, F., Kuppig, A., Klinghammer, K. F., Kaufmann, A. M., et al. (2021) · Cells · doi:10.3390/cells10030517 · Cited by 25
Schwestermann, J., Bešše, A., Driessen, C., & Bešše, L. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.899272 · Cited by 27
Self-citationPerspectives and mechanisms for targeting ferroptosis in the treatment of hepatocellular carcinoma
Li, L., Wang, X., Xu, H., Liu, X., & Xu, K. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.947208 · Cited by 25
Patel, K., Ahmed, Z. S. O., Huang, X., Yang, Q., Ekinci, E., Neslund-Dudas, C. M., Mitra, B., Elnady, F., Ahn, Y., Yang, H., et al. (2018) · Future Medicinal Chemistry · doi:10.4155/fmc-2018-0091 · Cited by 25
Self-citationFalls, K. C., Sharma, R. A., Lawrence, Y. R., Amos, R. A., Advani, S. J., Ahmed, M. M., Vikram, B., Coleman, C. N., & Prasanna, P. G. S. (2018) · Radiation Research · doi:10.1667/rr15121.1 · Cited by 27
Sarwono, A. E. Y., Mitsuhashi, S., Kabir, M. H. B., Shigetomi, K., Okada, T., Ohsaka, F., Otsuguro, S., Maenaka, K., Igarashi, M., Kato, K., et al. (2018) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2018.1540474 · Cited by 25
Tang, H., Cai, Y., Liu, C., Zhang, J.-T., Kankala, R. K., Wang, S., & Chen, A. (2020) · Journal of CO2 Utilization · doi:10.1016/j.jcou.2020.101187 · Cited by 25
Disulfiram and 6-Thioguanine synergistically inhibit the enzymatic activities of USP2 and USP21
Lin, H.-C., Kuan, Y., Chu, H.-F., Cheng, S.-C., Pan, H.-C., Chen, W.-Y., Sun, C.-Y., & Lin, T.-H. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.02.072 · Cited by 24
Hao, D., Luo, W., Yan, Y., & Zhou, J. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117182 · Cited by 24
Zhang, J., Pu, K., Bai, S., Peng, Y.-K., Fan, L., Ji, R., Guo, Q., Sun, W., & Wang, Y. (2020) · Journal of International Medical Research · doi:10.1177/0300060520925996 · Cited by 24
Intestinal microbiota regulates anti‐tumor effect of disulfiram combined with Cu2+ in a mice model
Hu, H., Cui, L., Lu, J., Wei, K., Wei, J., Li, S., Zou, C., & Chen, T. (2020) · Cancer Medicine · doi:10.1002/cam4.3346 · Cited by 24
Huang, Z., Luo, Y., Zhang, T., Ding, Y., Chen, M., Chen, J., Liu, Q., Huang, Y., & Zhao, C. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202203500 · Cited by 24
Hughes, R. E., Elliott, R. J. R., Li, X., Munro, A. F., Makda, A., Carter, R. N., Morton, N. M., Fujihara, K. M., Clemons, N. J., Fitzgerald, R. C., et al. (2022) · ACS Chemical Biology · doi:10.1021/acschembio.2c00301 · Cited by 25
Solovieva, M. E., Shatalin, Y. V., Odinokova, I. V., Krestinina, O. V., Baburina, Y. L., Mishukov, A. A., Lomovskaya, Y. V., Pavlik, L., Mikheeva, I. B., Holmuhamedov, E., et al. (2022) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2022.130184 · Cited by 24
Ni, Y., Chien, P., Hsieh, H.-C., Shen, H., Lee, H., Chen, S.-M., & Chang, W. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113276 · Cited by 24
The effect of lipid metabolism on cuproptosis-inducing cancer therapy
Zhong, Y., Zeng, W. G., Chen, Y., & Zhu, X. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116247 · Cited by 24
Guo, W., Jia, L., Xie, L., Kiang, J. G., Wang, Y., Sun, F., Lin, Z., Wang, E., Zhang, Y., Huang, P., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06644-3 · Cited by 30
Universal Anticancer Cu(DTC)2 Discriminates between Thiols and Zinc(II) Thiolates Oxidatively
Xu, L., Xu, J., Zhu, J., Yao, Z., Yu, N., Deng, W., Wang, Y., & Lin, B. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201814519 · Cited by 24
Lu, X., Lin, B., Xu, N., Huang, H., Wang, Y., & Lin, J.-M. (2020) · Talanta · doi:10.1016/j.talanta.2020.120732 · Cited by 23
Neuroblastoma—A Review of Combination Immunotherapy
Pieniążek, B., Cencelewicz, K., Bździuch, P., Młynarczyk, Ł., Lejman, M., Zawitkowska, J., & Derwich, K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147730 · Cited by 23
p97/VCP is required for piecemeal autophagy of aggresomes
Körner, M., Müller, P., Das, H. J., Kraus, F., Pfeuffer, T., Spielhaupter, S., Oeljeklaus, S., Schülein‐Völk, C., Harper, J. W., Warscheid, B., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59556-x · Cited by 25
Ruan, J., Rothan, H. A., Zhong, Y., Yan, W., Henderson, M. J., Chen, F., & Fang, S. (2019) · Scientific Reports · doi:10.1038/s41598-019-47532-7 · Cited by 23
Reporter-Based Screens for the Ubiquitin/Proteasome System
Gierisch, M. E., Giovannucci, T. A., & Dantuma, N. P. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.00064 · Cited by 23
Cao, X., Li, R., Xiong, H., Su, J., Guo, C., An, T., Zong, H., & Zhao, R. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113520 · Cited by 23
Photothermally Triggered Copper Payload Release for Cuproptosis‐Promoted Cancer Synergistic Therapy
Zhou, J., Yu, Q., Song, J., Li, S., Li, X., Kang, B., Chen, H., & Xu, J. (2022) · Angewandte Chemie · doi:10.1002/ange.202213922 · Cited by 23
Zhang, S., Zong, Y., Chen, L., Li, Q., Li, Z., & Meng, R. (2023) · Discover Oncology · doi:10.1007/s12672-023-00729-9 · Cited by 23
Targeting VCP potentiates immune checkpoint therapy for colorectal cancer
Wang, F., Qi, Q., Qin, B., Wang, Y., Huang, Y., Li, Q., Shen, X. H., Wang, X., Yang, S., Pan, G., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113318 · Cited by 23
Bu, W., Wang, Z., Meng, L., Li, X., Liu, X., Chen, Y., Xin, Y., Li, B., & Sun, H. (2019) · Cancer Management and Research · doi:10.2147/cmar.s199912 · Cited by 23
Solovieva, M. E., Shatalin, Y. V., Фадеев, Р. С., Krestinina, O. V., Baburina, Y. L., Kruglov, A. G., Kharechkina, E. S., Kobyakova, M. I., Rogachevsky, V. V., Shishkova, E. A., et al. (2020) · Biomolecules · doi:10.3390/biom10010069 · Cited by 23
Multifaceted role of GCN2 in tumor adaptation and therapeutic targeting
Chen, C., Xie, Y., & Qian, S. (2024) · Translational Oncology · doi:10.1016/j.tranon.2024.102096 · Cited by 24
Bioactive metallic nanoparticles for synergistic cancer immunotherapy
Wang, L., Lin, D., Li, M., Yu, J., Yang, Y., Wang, H., Chu, H., Ye, J., & Liu, Y. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.02.022 · Cited by 22
Zhao, P., Tang, X., & Huang, Y. (2021) · Open Research (University of Surrey) · doi:10.1002/viw.20200127 · Cited by 22
Liu, H., Kong, Y., Liu, Z., Guo, X., Yang, B., Yin, T., He, H., Gou, J., Zhang, Y. X., & Tang, X. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.121788 · Cited by 22
Toda, E., Sawada, A., Takeuchi, K., Wakamatsu, K., Ishikawa, A., Kuwahara, N., Sawa, Y., Hatanaka, S., Kokubo, K., Makino, K., et al. (2022) · Kidney International · doi:10.1016/j.kint.2022.07.031 · Cited by 22
Jiapaer, Z., Zhang, L., Ma, W., Liu, H., Li, C., Huang, W., & Shao, S. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.10.027 · Cited by 22
Ni, X., Ye, C., Xi, Y., Zhang, Y., Hou, Y., Zheng, Q., Chen, Z., Wang, L., Weng, X., Yang, C., et al. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.176110 · Cited by 23
Miao, L., Su, J., Zhuo, X., Luo, L., Kong, Y., Gou, J., Yin, T., Zhang, Y. X., He, H., & Tang, X. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b01094 · Cited by 22
Meng, Z., Wang, H., Fang, X., Liu, Z., Yang, Z., Yong, J., Yang, Q., Bai, Y., Ren, H., Xu, H., et al. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c09346 · Cited by 22
Targeting non-canonical pathways as a strategy to modulate the sodium iodide symporter
Read, M. L., Brookes, K., Thornton, C. E. M., Fletcher, A., Nieto, H. R., Alshahrani, M., Khan, R., de Souza, P. B., Zha, L., Webster, J., et al. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.07.016 · Cited by 22
The Promiscuity of Disulfiram in Medicinal Research
Cvek, B. (2023) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.3c00450 · Cited by 21
Self-citationCuproptosis in cancer: from molecular mechanisms to therapeutic intervention
Jiang, D., Zhuang, L., Koong, A. C., & Gan, B. (2025) · Trends in cancer · doi:10.1016/j.trecan.2025.12.002 · Cited by 22
VCP/p97 targets the nuclear export and degradation of p27 Kip1 during G1 to S phase transition
Shi, X., Zhu, K., Ye, Z., & Yue, J. (2020) · The FASEB Journal · doi:10.1096/fj.201901506r · Cited by 21
New perspectives on ferroptosis and its role in hepatocellular carcinoma
Cong, T., Luo, Y., Fu, Y. H. H., Liu, Y., Li, Y., & Li, X. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002327 · Cited by 21
Abu-Serie, M. M., & Abdelfattah, E. Z. A. (2023) · Scientific Reports · doi:10.1038/s41598-023-30553-8 · Cited by 21
Xu, X., Han, Y., Deng, J., Wang, S., Zhuo, S., Zhao, K., & Zhou, W. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.03.003 · Cited by 23
Kawamoto, M., Umebayashi, M., Tanaka, H., Koya, N., Nakagawa, S., Kawabe, K., Onishi, H., Nakamura, M., & Morisaki, T. (2018) · Anticancer Research · doi:10.21873/anticanres.12516 · Cited by 21
Huang, X., Wang, Y., Hong, P., Yang, J., Zheng, C., Yin, X., Song, W., Xu, W. W., Li, B., & He, Q. (2019) · PubMed Central · Cited by 21
Xu, L., Chen, Q., Qian, Y., Wang, J., Wang, C., Fan, R., Shen, J., & Shen, Q. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.161733 · Cited by 22
When essential metal elements become culprits—Cuproptosis in focus
Hu, J., & Jiang, X. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.05.008 · Cited by 20
Nanoparticles induced cuproptosis to enhance antitumor immunotherapy
Deng, W., Zhong, Z., Shang, H., Tong, Y., Huang, Q., Yu, H., Wu, J., Ba, X., Chen, Z., Chen, Y., et al. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03616-3 · Cited by 21
Drug Repurposing in Oncology: Current Evidence and Future Direction
Zhang, Z., Ji, J., & Liu, H. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327999200820124111 · Cited by 20
Wang, H., Xiao, X., Li, Z., Luo, S., Hu, L., Yi, H. J., Xiang, R., Zhu, Y., Wang, Y., Zhu, L., et al. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215647 · Cited by 20
Peng, Y., Liu, P., Ding, J., & Zhou, W. (2023) · Chemical Engineering Journal · doi:10.1016/j.cej.2023.146277 · Cited by 20
Access to disulfides through ligand-controlled nickel-catalyzed dithiosulfonate and alkyl halides
Chen, W., Liu, X.-Y., Sheng, D., Jiang, Y., Rao, W., Shen, S., Yang, Z., & Wang, S. (2023) · Organic Chemistry Frontiers · doi:10.1039/d3qo01868g · Cited by 20
Li, B., Liu, B.-X., Rao, W., Shen, S., Sheng, D., & Wang, S. (2024) · Organic Letters · doi:10.1021/acs.orglett.4c01109 · Cited by 20
Komarova, T. V., Sheshukova, E. V., Kosobokova, E. N., Kosorukov, V. S., Shindyapina, A. V., Lipskerov, F. A., Shpudeiko, P. S., Евгеньевна, Б. Т., & Dorokhov, Y. L. (2019) · Scientific Reports · doi:10.1038/s41598-019-52507-9 · Cited by 20
Gruber, F. S., Johnston, Z. C., Barratt, C. L. R., & Andrews, P. D. (2020) · eLife · doi:10.7554/elife.51739 · Cited by 20
Liu, Y., Tang, R., Cao, Y., Wu, N., Qin, Q., Chen, Y., Wei, X., Ren, J., Sun, Y., Zhou, H., et al. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02492-7 · Cited by 19
Addressing misconceptions in dithiocarbamate chemistry
Pugh, D., & Hogarth, G. (2025) · Dalton Transactions · doi:10.1039/d5dt01085c · Cited by 19
Wang, Y.-E., Yang, H. S., Zhao, S., Tian, L., Wu, W., Chen, Y., Wu, X., Zhang, T., Linghu, K., Liu, S., et al. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.146920 · Cited by 19
Copper Complexes: Main Mechanisms as Anticancer Agents
Hangan, A. C., Oprean, L. S., Procopciuc, L. M., Dican, L., Gog-Bogdan, S., & Lucaciu, R. L. (2026) · Molecules · doi:10.3390/molecules31050874 · Cited by 19
Wang, D., Xiao, L., Xiong, M., Zhu, H., Zhou, Y., & Pan, Y. (2020) · Organic & Biomolecular Chemistry · doi:10.1039/d0ob00804d · Cited by 19
Hu, X., Li, R., Liu, J., Fang, K., Dong, C., & Shi, S. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202302333 · Cited by 19
Disulfiram mediated anti-tumour effect in pituitary neuroendocrine tumours by inducing cuproptosis
Huang, N., Feng, Y., Liu, Y., Zhang, Y., Liu, L., Zhang, B., Zhang, T., Su, Z., Li, X., & Wu, Z. B. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112159 · Cited by 20
N -Oxide polymer–cupric ion nanogels potentiate disulfiram for cancer therapy
Zhong, Y., Sun, R., Geng, Y., Zhou, Q., Piao, Y., Xie, T., Zhou, R., & Shen, Y. (2020) · Biomaterials Science · doi:10.1039/c9bm01841g · Cited by 19
Sweeney, H. L., Masiero, S., & Carraro, U. (2022) · European Journal of Translational Myology · doi:10.4081/ejtm.2022.10440 · Cited by 19
Xu, L., Sun, Y., Li, Y., Sun, J., Guo, Y., Shen, Q., Wei, Q., & Shen, J. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.122130 · Cited by 19
Targeting the unfolded protein response in head and neck and oral cavity cancers
Cole, D. W., Svider, P. F., Shenouda, K. G., Lee, P. B., Yoo, N. G., McLeod, T. M., Mutchnick, S. A., Yoo, G. H., Kaufman, R. J., Callaghan, M. U., et al. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.04.007 · Cited by 19
Zha, J., Bi, S., Deng, M., Chen, K., Shi, P., Feng, L., He, J., Pu, X., Guo, C., Zhao, H., et al. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174107 · Cited by 18
Research progress on cuproptosis and copper related anti-tumor therapy
Li, Y., Han, L., & Hu, H. (2025) · Discover Oncology · doi:10.1007/s12672-025-02335-3 · Cited by 20
Wang, J., Tian, Q., Liu, Y., Cai, C., Fu, S., Li, J., Guan, Y., Liao, X., Su, D., Sun, T., et al. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02414-7 · Cited by 18
Self-citationTargeting cuproptosis with nanomaterials for cancer immunotherapy
Cui, P.-P., Yang, Q.-C., & Sun, Z. (2025) · Acta Biomaterialia · doi:10.1016/j.actbio.2025.11.028 · Cited by 18
Applications of copper based metal organic frameworks
Singh, N., & Thakur, A. (2021) · Materials Today Proceedings · doi:10.1016/j.matpr.2021.09.264 · Cited by 18
Drug Repurposing Strategies for Non-cancer to Cancer Therapeutics
Singhal, S., Maheshwari, P., Krishnamurthy, P. T., & Patil, V. M. (2022) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520622666220317140557 · Cited by 18
Cao, H.-Z., Yang, W., & Zheng, P. (2022) · BMC Cancer · doi:10.1186/s12885-022-09574-5 · Cited by 19
Effects and Mode of Action of Oleic Acid and Tween 80 on Skin Permeation of Disulfiram
Saitoh, H., Takami, K., Ohnari, H., Chiba, Y., Ikeuchi-Takahashi, Y., & Obata, Y. (2023) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c22-00821 · Cited by 18
Lin, J., Huang, C., Wang, P., He, Y., Luo, Q., Liu, X., & Li, Y. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202303955 · Cited by 18
Disulfiram-loaded CuO2 nanocarriers for enhanced synergistic chemodynamic chemotherapy
Hu, W., Yang, L., Liao, H., Sun, D., Ouyang, X., Wang, N., & Yang, G. (2024) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2024.06.147 · Cited by 18
Huang, X., Sun, P., Qin, Y., Wang, X., Wang, M., Lin, Y., Zhou, R., Hu, W., Liu, Q., Yu, X., et al. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108453 · Cited by 18
Zhang, Y., Qi, G., Qu, X., Wang, B., Ma, K., & Jin, Y. (2021) · Langmuir · doi:10.1021/acs.langmuir.1c03256 · Cited by 18
Novel insights into cuproptosis inducers and inhibitors
Zhang, L., Deng, R., Liu, L., Du, H., & Tang, D. (2024) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2024.1477971 · Cited by 18
Imam, M., Ji, J., Zhang, Z., & Yan, S. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1493188 · Cited by 18
Old drugs, new challenges: reassigning drugs for cancer therapies
Czechowicz, P., Więch, A., Sławski, J., Collawn, J. F., & Bartoszewski, R. (2025) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-025-00710-0 · Cited by 19
Cui, J., Li, W., Bu, W., Liu, J., Chen, X., Li, X., Liu, C., Meng, L., Chen, M., Sun, H., et al. (2022) · Biomaterials Advances · doi:10.1016/j.bioadv.2022.213038 · Cited by 17
Disulfiram increases the efficacy of 5-fluorouracil in organotypic cultures of colorectal carcinoma
Hendrych, M., Říhová, K., Adamová, B., Hradil, V., Stiborek, M., Vlček, P., Hermanová, M., Vašíčková, J., Beneš, P., Šmarda, J., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113465 · Cited by 17
Ikebukuro, T., Arima, T., Kasamatsu, M., Nakano, Y., Tobita, Y., Uchiyama, M., Terashima, Y., Toda, E., Shimizu, A., & Takahashi, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24010735 · Cited by 17
Bagherpoor, A. J., Shameem, M., Luo, X., Seelig, D. M., & Kassie, F. (2023) · Carcinogenesis · doi:10.1093/carcin/bgad020 · Cited by 17
A Novel Oncogenic Role of FDX1 in Human Melanoma Related to PD-L1 Immune Checkpoint
Lu, H., Liang, J., He, X., Ye, H., Ruan, C., Shao, H., Zhang, R., & Li, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119182 · Cited by 17
Jiang, S., Fu, W., Wang, S., Zhu, G., Wang, J., & Ma, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241311222 · Cited by 19
Coordinating effect of ferroptosis and in situ disulfiram toxification for enhanced cancer therapy
Meng, X., Wu, J., Hu, Z., Zheng, X., & Wang, Z. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.149313 · Cited by 17
Zhang, C., Cui, M., Cui, Y., Hettinghouse, A., & Liu, C.-J. (2019) · Journal of Visualized Experiments · doi:10.3791/59656 · Cited by 17
Dithiocarbamate prodrugs activated by prostate specific antigen to target prostate cancer
Bakthavatsalam, S., Wiangnak, P., George, D. J., Zhang, T., & Franz, K. J. (2020) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2020.127148 · Cited by 17
Khan, R. A., Khan, M. R., Usman, M., Sayeed, F., Al‐Ghamdi, H. A., Alrumman, S. A., Alharbi, W., Farshori, N. N., Al-Oqail, M. M., Siddiqui, M. R., et al. (2020) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2020.05.001 · Cited by 17
Chromá, K., Škrott, Z., Gurský, J., Bačovský, J., Moudrý, P., Buchtová, T., Mistrík, M., & Bártek, J. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04651-w · Cited by 17
Emerging long noncoding RNA polymorphisms as novel predictors of survival in cancer
Abdi, E., & Latifi‐Navid, S. (2022) · Pathology - Research and Practice · doi:10.1016/j.prp.2022.154165 · Cited by 17
Cuproptosis in cancer therapy: mechanisms, therapeutic application and future prospects
Hu, J., Zhu, J., Chen, T., Zhao, Y., Xu, Q., & Wang, Y. (2024) · Journal of Materials Chemistry B · doi:10.1039/d4tb01877j · Cited by 17
Metadata
- Authors
- Skrott, Z., Mistrik, M., Andersen, K. K., Friis, S., Majera, D., Gursky, J., Ozdian, T., Bartkova, J., Turi, Z., Moudry, P., Kraus, M., Michalova, M., Vaclavkova, J., Dzubak, P., Vrobel, I., Pouckova, P., Sedlacek, J., Miklovicova, A., Kutt, A., Li, J., Mattova, J., Driessen, C., Dou, Q. P., Olsen, J., Hajduch, M., Cvek, B., Deshaies, R. J., & Bartek, J.
- Affiliations
- Danish Cancer Society (DK)
- Institute of Molecular and Translational Medicine (CZ)
- Kantonsspital St. Gallen (CH)
- Charles University (CZ)
- Nemocnice Šternberk (CZ)
- California Institute of Technology (US)
- Wayne State University (US)
- Palacký University Olomouc (CZ)
- Corresponding author
- Cvek, Boris
- Deshaies, Raymond J.
- ORCID
- Venue
- Nature
- Published
- 2017-12
- Volume
- 552
- Issue
- 7684
- Pages
- 194-199
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC5730499
- OpenAlex
- W2772508026
- Cited by
- 807
- References
- 53
- Citations by year
- 2026: 76 · 2025: 108 · 2024: 120 · 2023: 108 · 2022: 112 · 2021: 81 · 2020: 92 · 2019: 60 · 2018: 50
- FWCI
- 22.68
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- CaltechAUTHORS (California Institute of Technology) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- Lundbeckfonden (R93-2011-8990)
- National Cancer Institute (R01CA164803)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- disulfiram, drug repurposing, cancer, Npl4, VCP, diethyldithiocarbamate, cancer mortality, tumor suppression, protein turnover, stress response, biomarkers, cell death
- MeSH terms
- Adult, Alcohol Deterrents, Alcoholism, Animals, Antineoplastic Agents, Copper, Denmark, Disulfiram, Female, Humans, Male, Middle Aged, Neoplasms, Nuclear Proteins, Protein Binding, Heat-Shock Response, Mice, Drug Repositioning, Molecular Targeted Therapy, Proteolysis, Protein Aggregates
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
